ResearcherSecond Affiliated Hospital of Soochow UniversityNo recent work listed

Changjie Lin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8776-2184; OpenAlex author ID A5072436996. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper

Papers 2

Downregulation of USP34 Inhibits the Growth and Migration of Pancreatic Cancer Cells via Inhibiting the PRR11. Co-author DOI 10.2147/ott.s228857 ↗
USP34 Regulated Human Pancreatic Cancer Cell Survival via AKT and PKC Pathways. First author DOI 10.1248/bpb.b18-00646 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Zhiwei Gu · 2 shared papers, 2019–2020 · strength 0.25
- Paper Downregulation of USP34 Inhibits the Growth and Migration of Pancreatic Cancer Cells via Inhibiting the PRR11. DOI 10.2147/ott.s228857 ↗
- Paper USP34 Regulated Human Pancreatic Cancer Cell Survival via AKT and PKC Pathways. DOI 10.1248/bpb.b18-00646 ↗
Dekang Gao · 2 shared papers, 2019–2020 · strength 0.25
- Paper Downregulation of USP34 Inhibits the Growth and Migration of Pancreatic Cancer Cells via Inhibiting the PRR11. DOI 10.2147/ott.s228857 ↗
- Paper USP34 Regulated Human Pancreatic Cancer Cell Survival via AKT and PKC Pathways. DOI 10.1248/bpb.b18-00646 ↗
Shaohua Wei · 2 shared papers, 2019–2020 · strength 0.25
- Paper Downregulation of USP34 Inhibits the Growth and Migration of Pancreatic Cancer Cells via Inhibiting the PRR11. DOI 10.2147/ott.s228857 ↗
- Paper USP34 Regulated Human Pancreatic Cancer Cell Survival via AKT and PKC Pathways. DOI 10.1248/bpb.b18-00646 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.